tirzepatide subscription FDA says the weight-loss drug shortage is over GobyMeds - Compounded Tirzepatide GLP-1

Diabetic ketoacidosis (DKA) risk is a serious concern, particularly for patients using insulin or SGLT2 inhibitors with very-low-carbohydrate diets

Medicines that enable dramatic weight loss are likely to experience a new boom in uptake, experts have said, as the first generic versions hit the market this week at a lower cost than the original drugs

Fats should be used sparingly and come from whole food sources

3.3 Regulation of Energy Metabolism by GIPR Agonism and Antagonism Consistent with the proposed role of GIP in lipid storage, mice with global loss of Gipr are lean and exhibit decreased body weight gain when fed a high-fat diet (HFD) (177)

For example, Wegovy is licensed specifically to reduce cardiovascular risk in people with raised BMI something that becomes increasingly relevant during menopause